Tenet Healthcare (NYSE:THC) Price Target Raised to $104.00 at UBS Group

Tenet Healthcare (NYSE:THCFree Report) had its target price lifted by UBS Group from $95.00 to $104.00 in a research note released on Tuesday, MarketBeat.com reports. They currently have a buy rating on the stock.

THC has been the topic of several other research reports. Royal Bank of Canada boosted their price objective on Tenet Healthcare from $73.00 to $84.00 in a report on Wednesday, April 26th. Truist Financial lifted their target price on Tenet Healthcare from $84.00 to $92.00 in a research note on Tuesday, June 20th. Stephens lifted their target price on Tenet Healthcare from $87.00 to $89.00 and gave the company an equal weight rating in a research note on Tuesday. Cantor Fitzgerald began coverage on Tenet Healthcare in a research note on Thursday, April 20th. They set an overweight rating and a $73.00 target price on the stock. Finally, Raymond James lifted their target price on Tenet Healthcare from $72.00 to $85.00 in a research note on Wednesday, April 26th. One equities research analyst has rated the stock with a hold rating, thirteen have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, Tenet Healthcare currently has a consensus rating of Buy and an average target price of $80.24.

Tenet Healthcare Price Performance

Shares of Tenet Healthcare stock opened at $76.80 on Tuesday. The company’s 50-day moving average price is $77.19 and its two-hundred day moving average price is $66.65. The company has a current ratio of 1.39, a quick ratio of 1.29 and a debt-to-equity ratio of 5.79. The stock has a market cap of $7.83 billion, a PE ratio of 16.88, a price-to-earnings-growth ratio of 4.88 and a beta of 2.12. Tenet Healthcare has a 52 week low of $36.69 and a 52 week high of $85.40.

Tenet Healthcare (NYSE:THCGet Free Report) last posted its quarterly earnings data on Monday, July 31st. The company reported $1.44 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.26 by $0.18. The firm had revenue of $5.08 billion for the quarter, compared to the consensus estimate of $4.91 billion. Tenet Healthcare had a return on equity of 27.15% and a net margin of 2.51%. The business’s revenue for the quarter was up 9.6% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.50 EPS. As a group, sell-side analysts anticipate that Tenet Healthcare will post 5.71 EPS for the current fiscal year.

Insiders Place Their Bets

In other Tenet Healthcare news, EVP Thomas W. Arnst sold 21,178 shares of the company’s stock in a transaction that occurred on Friday, May 19th. The stock was sold at an average price of $73.12, for a total transaction of $1,548,535.36. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other Tenet Healthcare news, EVP Thomas W. Arnst sold 21,178 shares of the company’s stock in a transaction that occurred on Friday, May 19th. The stock was sold at an average price of $73.12, for a total transaction of $1,548,535.36. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Paola M. Arbour sold 38,556 shares of the company’s stock in a transaction that occurred on Friday, June 2nd. The stock was sold at an average price of $75.22, for a total value of $2,900,182.32. Following the transaction, the executive vice president now owns 33,006 shares of the company’s stock, valued at $2,482,711.32. The disclosure for this sale can be found here. Company insiders own 1.70% of the company’s stock.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the business. Beacon Capital Management LLC acquired a new position in shares of Tenet Healthcare in the fourth quarter valued at $27,000. Global Retirement Partners LLC raised its stake in shares of Tenet Healthcare by 434.4% in the second quarter. Global Retirement Partners LLC now owns 326 shares of the company’s stock valued at $27,000 after purchasing an additional 265 shares in the last quarter. Nvwm LLC acquired a new position in shares of Tenet Healthcare in the first quarter valued at $30,000. Householder Group Estate & Retirement Specialist LLC acquired a new position in shares of Tenet Healthcare in the first quarter valued at $31,000. Finally, Northwestern Mutual Wealth Management Co. raised its stake in shares of Tenet Healthcare by 46.3% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 629 shares of the company’s stock valued at $31,000 after purchasing an additional 199 shares in the last quarter. 96.07% of the stock is currently owned by institutional investors and hedge funds.

Tenet Healthcare Company Profile

(Get Free Report)

Tenet Healthcare Corporation operates as a diversified healthcare services company. The company operates through three segments: Hospital Operations, Ambulatory Care, and Conifer. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.

Featured Articles

Analyst Recommendations for Tenet Healthcare (NYSE:THC)

Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.